Titrimetric assay of lisinopril in aqueous and non-aqueous media
Article Sidebar
Main Article Content
Abstract
Four simple titrimetric procedures are described for the determination of lisinopril (LNP) in bulk and in pharmaceuticals based on the neutralization of basic-amino and acidic carboxylic acid groups present in LNP. Method A is based on the neutralization of basic amino groups using perchloric acid as titrant in anhydrous acetic acid medium. Method B, method C and method D are based on neutralization of carboxylic acid group using NaOH, sodium methoxide and methanolic KOH, as titrants, respectively. Method A is applicable over 2.0-20.0 mg range and the calculations are based in the molar ratio of 1:2 (LNP:HClO4). Method B, method C and method D are applicable over 2.0-20.0 mg, 1.0-10.0 mg and 5.0-15.0 mg range, respectively, and their respective molar ratios are 1:1 (LNP:NaOH), 1:2 (LNP:CH3ONa) and 1:1 (LNP:KOH). Intraday and inter day accuracy and precision of the methods were evaluated and the results showed intra- and inter-day precision less than 2.7% (RSD), and accuracy of < 2.5% (RE). The developed methods were applied to determine LNP in tablets and the results were validated statistically by comparing the results with those of the reference method by applying the Student’s t-test and F-test.
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
The corresponding author transfers the copyright of the submitted manuscript and all its versions to Eclet. Quim., after having the consent of all authors, which ceases if the manuscript is rejected or withdrawn during the review process.
When a published manuscript in EQJ is also published in other journal, it will be immediately withdrawn from EQ and the authors informed of the Editor decision.
Self-archive to institutional, thematic repositories or personal webpage is permitted just after publication. The articles published by Eclet. Quim. are licensed under the Creative Commons Attribution 4.0 International License.
References
Parfitt, K. “The Complete Drug Reference”. (1999) 32nd
ed. 898. The Pharamaceutical Press, Martindalle, MA.
The British Pharmacopoeia, Her Majesty’s Stationary Office, London, (1998) pp. 799.
The US Pharmacopoeia, 24th revision, Asian Edition, United States Pharmacopoeial Convention, INC, Twinbrook Parkway, Rockville, MD, (2000), pp. 979 and pp. 2149.
G. Parashevas, J. Atta-Politou, M. Koupparis, J. Pharm. Biomed. Anal 8 (2002) 865.
A. Rajasekaran, S. Udayavani, J Indian Chem Soc., 78 (2001) 485.
F.A El-Yazbi, H.H. Abdine, R.A. Shaalan, J. Pharm. Biomed. Anal, 19 (1999) 819.
A. El-Gindy, A. Ashour, L. Abdel-Fattah, M.M. Shabana, J. Pharm. Biomed. Anal 25 (2001) 923.
N. Rahman, N. Anwar, M. Kashif, Farmaco 60 (2005) 605.
R. Asad, M.A. Tariq, U.R. Atta, J. Chin. Chem. Soc 52 (2005) 1055.
R. Nafisur, S. Manisha, H. Md. Nasrul, J. Braz. Chem. Soc 16 (2005) 1001.
N. Rahman, M.R. Siddiqui, S.N.H. Azmi, Chem. Anal. (Warsaw) 52 (2007) 465.
O. Abdel Razak, S.F. Belal, M.M. Bedair, N.S. Barakat, R.S. Haggag, J. Pharm. Biomed. Anal 31 (2003) 701-711.
S.A. Esra, E. Lale, S. Olcay, II Farmaco 58 (2003)165. [14] C. Zacharis, P. Tzanavaras, , D. Themelis, , G. Theodoridis, , A. Economou, P. Rigas, Anal. Bioanal. Chem 379 (2004) 759.
O. Durisehvar, S. Hulya, J. Pharm. Biomed. Anal. 21(1999) 691.
A. El-Gindy, A. Ashour, L. Abdel-Fattah, M.M. Shabana, J. Pharm. Biomed. Anal 25 (2001) 923.
S. Beata, Acta. Pol. Pharm 61 (2005) 327.
D. Bonazzi, R. Gotti, V. Andrisano, V. Cavrini, J. Pharm. Biomed. Anal 16 (1997) 431.
C.V.N. Prasad, R.N. Saha, P. Parimoo, Pharm. Pharmacol. Commun 5 (1999) 383.
D. Ozer, H. Senel, J. Pharm. Biomed. Anal 21 (1999) 691.
R.C. Mashru, P.P. Parikh, East. Pharm 43 (2000)111.
H.K. Jain, R.K. Agrawal, Indian Drugs 37 (2000) 196.
N. Erk, Spectrosc-Lett., 31 (1998) 633.
N. El-Enany, F. Belal, S. Al-Ghannam, Mikrochim. Acta 141 (2003) 55.
A. Rajasekaran, S. Murugesan, Asian J. Chem 13 (2001) 1245.
A.B. Avadhanulu, A.R.R. Pantulu, Indian Drugs 30 (1993) 646.
S. Hillaert, K. De Grauwe, and B.W. Van den, J. Chromatogr. A 924 (2001) 439.
D. Ivanoic, M. Medenica, B. Jancic, N. Knezevic, Acta Chromatogr 18 (2007) 143.
E.R.K. Nevin, K. Murat, Ana. Lett 32 (1999) 1131.
R.T. Sane, G.R. Valiyare, U.M. Deshmukh, S.R. Singh, R. Sodhi, Indian Drugs 29 (1992) 558.
A.B. Christopher, S. Jessica, Z. Zack, A.R. Robert, J. Pharm. Biomed. Anal 37 (2004) 559.
S.S.M. Hassan, M.B. Elsayes, Mikrochimica Acta (1973) 801-807.
J.S. Fritz and R.T. Keen, Anal. Chem 25 (1953)179-181.
J.S. Firtz and N.M. Lisicki, Anal. Chem 23 (1951) 589.
J. Firtz. Anal. Chem 24 (1952) 306.
International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and ethodology Q2(R1), Complementary Guideline on Methodology dated 06
November 1996, incorporated in November 2005, London.